Olema Pharmaceuticals Inc stock is traded at $6.76, with a volume of 1,706,457. It is down -10.34% in the last 24 hours and down -18.06% over the past month. Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
Previous Close:
$7.54
Open:
$7.49
24h Volume:
1,706,457
Relative Volume:
1.17
Market Cap:
$591.48M
Revenue:
-
Net Income/Loss:
-$185.15M
P/E Ratio:
-
EPS:
-$2.03
Net Cash Flow:
-$148.72M
1W Performance:
-7.78%
1M Performance:
-18.06%
6M Performance:
-53.83%
1Y Performance:
-14.97%
1-Day Range:
$6.71$7.52
1-Week Range:
$6.71$7.62
52-Week Range:
$6.24$36.26
Olema Pharmaceuticals Inc Stock (OLMA) Company Profile
Name
Olema Pharmaceuticals IncSector
HealthcareIndustry
BiotechnologyPhone
(415) 651-3316Address
780 BRANNAN STREET, SAN FRANCISCO, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS